Microbial marker combination, method, system, equipment and medium for diagnosing or predicting type 2 diabetes mellitus

Mendel randomized analysis screens the combination of intestinal microbial markers and builds a machine learning model, which solves the problem of poor correlation of the characteristic value of the type 2 diabetes prediction model in the existing technology, realizes high-accuracy diagnosis and prediction, and has clinical applications value.

CN119069059AActive Publication Date: 2024-12-03ZHEJIANG DIGENA DIAGNOSTIC TECH CO LTD

Patent Information

Application Number
CN202411545596.3
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-11-01
Publication Date
2024-12-03
Estimated Expiration
2044-11-01

AI Technical Summary

Technical Problem

In the prior art, the characteristic value of the type 2 diabetes prediction model based on intestinal microbial markers is poorly correlated with the disease, resulting in difficulty in explaining causal correlations and being unable to effectively diagnose or predict type 2 diabetes.

Method used

Mendel randomization analysis screened out the combination of intestinal microbial markers that had a causal relationship with type 2 diabetes, including Anaerostipes, Lactococcus, Gordonibacter, etc., combined with machine learning models to build diagnostic or predictive models, and used microbial marker abundance data to perform two Diagnosis and risk prediction of type diabetes.

Benefits of technology

Highly accurate diagnosis and prediction of type 2 diabetes were achieved, with the training set AUC reaching 0.9703, the verification set AUC reaching 0.9190, and the independent verification set AUC is 0.8264, which has clinical application value.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119069059A_ABST
    Figure CN119069059A_ABST
Patent Text Reader

Abstract

The invention discloses a microbial marker combination, a method, a system, equipment and a medium for diagnosing or predicting type 2 diabetes mellitus, and belongs to the technical field of microbial markers. The microbial marker combination provided by the invention can be used for accurately diagnosing whether a subject suffers from type 2 diabetes or predicting whether the subject has the risk of suffering from type 2 diabetes. Furthermore, on the basis of a specific machine learning model, accurate prediction can be realized on the basis of the obtained high-low degree of the type 2 diabetes risk of the predicted subject, so that medical intervention can be carried out in time, and the method has a huge clinical application value.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention belongs to the technical field of microbial markers, and specifically relates to a microbial marker combination, method, system, device and medium for diagnosing or predicting type 2 diabetes. Background Art

[0002] Diabetes is a chronic disease caused by insufficient insulin secretion or utilization. Type 2 diabetes is the most common type of diabetes, accounting for approximately 90% of cases and occurring primarily in adults. It is a clinical syndrome characterized by impaired glucose metabolism, caused by a combination of genetic and environmental factors. Factors currently believed to influence the development of diabetes include age, obesity level, body fat distribution, lifestyle, blood sugar levels, and insulin levels. Furthermore, studies have found a close relationship between the gut microbiome and type 2 diabetes, with diabetic patients susceptible to gut microbial imbalance, which can impact energy metabolism and inflammatory responses.

[0003] The bacteria, viruses, and single-celled eukaryotic organisms that inhabit the human intestine are commonly referred to as the gut microbiota. These microbes, primarily bacteria, are diverse and numerous. The gut microbiota comprises over 1,000 species and numbers as many as 100 trillion, ten times the number of cells in the human body. The sum of the genes in the gut microbiota, known as the "human metagenome," encodes at least 150 times more genes than the human genome itself. 16S rRNA sequencing of the gut microbiota revealed that over 90% belong to the Bacteroidetes and Firmicutes phyla. These two phyla dominate the human gut, including genera such as Bacteroidetes, Prevotella, Clostridium, Enterococcus, Lactobacillus, and Ruminococcus. Other less abundant phyla include Actinobacteria, Proteobacteria, Verrucomicrobia, and methanogenic Archaea. From birth, microbes interact and influence the body. Microbes and their metabolites contribute to the maturation of physiological functions, co-evolving with the host and continuously influencing human health.

[0004] As an internal environmental factor, intestinal flora is closely related to type 2 diabetes. There are significant differences in the intestinal flora between healthy people and people with type 2 diabetes in terms of categories and species. Studies have found that the overall number of bifidobacteria and lactobacilli in the intestines of patients with type 2 diabetes is significantly reduced; the number of Bacteroidetes and Proteobacteria increases, while the number of Firmicutes decreases relatively. The proportion of β-Proteobacteria is significantly increased in people with diabetes and is positively correlated with the degree of increase in blood sugar concentration. In addition, studies have shown that Roseburia ( Roseburia ), Eubacterium hallii ( Eubacterium halii ), Faecalibacterium prausnitzii ( Faecalibacterium prauznitzii ) reduce, Lactobacillus gasseri ( Lactobacillus gasseri ), Streptococcus mutans ( Streptococcus mutans ), Escherichia coli ( E.coli ) increases, which can serve as a potential clinical diagnostic marker for type 2 diabetes.

[0005] Therefore, screening gut microbial markers and predicting the risk of type 2 diabetes using machine learning models can help better prevent type 2 diabetes. Currently, there are no reliable prediction models for type 2 diabetes based on gut microbial markers. The feature values ​​of some prediction models have a poor correlation with type 2 diabetes and a low causal relationship, which often results in the feature being unable to explain the relationship with type 2 diabetes. Summary of the Invention

[0006] In order to solve at least one of the above technical problems, the inventors obtained intestinal microbial markers that are causally related to type 2 diabetes through Mendelian randomization analysis, and further explored their causal relationship with type 2 diabetes. The markers obtained are all intestinal microorganisms that are causally related to type 2 diabetes, which can better perform diagnosis or prediction.

[0007] The first aspect of the present invention provides a microbial marker combination for diagnosing or predicting type 2 diabetes, the microbial marker combination comprising Anaerostipes 、 Lactococcus 、 Gordonibacter 、 Parasutterella 、 Lachnoclostridium 、 Parabacteroides 、 Actinomyces 、 Desulfovibrio 、 Dialister 、 Butyricimonas 、 Paraprevotella 、 Holdemanella 、 Methanobrevibacter 、 Anaerotruncus 、 Alloprevotella 、 Collinsella 、 Akkermansia 、 Alistipes 、 Sutterella 、 Lactobacillus 、 Intestinibacter 、 Flavonifractor 、 Odoribacter 、 Veillonella 、 Barnesiella 、 Olsenella 、 Adlercreutzia 、 Oscillibacter 、 Streptococcus 、 Haemophilus and Bacteroides .

[0008] In some preferred embodiments of the present invention, the microbial marker combination includes Anaerostipes 、 Intestinibacter 、 Oscillibacter 、 Streptococcus 、 Bacteroides .

[0009] In some more preferred embodiments of the present invention, the microbial marker combination includes Anaerostipes 、 Intestinibacter 、 Barnesiella 、 Oscillibacter 、 Streptococcus 、 Bacteroides .

[0010] In some more preferred embodiments of the present invention, the microbial marker combination includes Anaerostipes 、 Intestinibacter 、 Flavonifractor 、 Barnesiella 、 Oscillibacter 、 Streptococcus 、 Bacteroides .

[0011] In some more preferred embodiments of the present invention, the microbial marker combination includes Anaerostipes 、 Lactobacillus 、 Intestinibacter 、 Flavonifractor 、 Barnesiella 、 Oscillibacter 、 Streptococcus 、 Bacteroides .

[0012] In some more preferred embodiments of the present invention, the microbial marker combination includes Anaerostipes 、 Parabacteroides 、 Lactobacillus 、 Intestinibacter 、 Flavonifractor 、 Barnesiella 、 Oscillibacter 、 Streptococcus 、 Bacteroides .

[0013] In some more preferred embodiments of the present invention, the microbial marker combination includes Anaerostipes 、 Parabacteroides 、 Anaerotruncus 、 Lactobacillus 、 Intestinibacter 、 Flavonifractor 、 Barnesiella 、 Oscillibacter 、 Streptococcus 、 Bacteroides .

[0014] In some more preferred embodiments of the present invention, the microbial marker combination includes Anaerostipes 、 Parabacteroides 、 Dialister 、 Anaerotruncus 、 Lactobacillus 、 Intestinibacter 、 Flavonifractor 、 Barnesiella 、 Oscillibacter 、 Streptococcus 、 Bacteroides .

[0015] In some more preferred embodiments of the present invention, the microbial marker combination includes Anaerostipes 、 Parabacteroides 、 Dialister 、 Anaerotruncus 、 Alistipes 、 Lactobacillus 、 Intestinibacter 、 Flavonifractor 、 Barnesiella 、 Oscillibacter 、 Streptococcus 、 Bacteroides .

[0016] In some more preferred embodiments of the present invention, the microbial marker combination includes Anaerostipes 、 Parabacteroides 、 Dialister 、 Anaerotruncus 、 Alistipes 、 Lactobacillus 、 Intestinibacter 、 Flavonifractor 、 Barnesiella 、 Olsenella 、 Oscillibacter 、 Streptococcus 、 Bacteroides .

[0017] In some more preferred embodiments of the present invention, the microbial marker combination includes Anaerostipes 、 Lachnoclostridium 、 Parabacteroides 、 Dialister 、 Anaerotruncus 、 Alistipes 、 Lactobacillus 、 Intestinibacter 、 Flavonifractor 、 Barnesiella 、 Olsenella 、 Oscillibacter 、 Streptococcus 、 Bacteroides .

[0018] In some more preferred embodiments of the present invention, the microbial marker combination includes Anaerostipes 、 Lachnoclostridium 、 Parabacteroides 、 Dialister 、 Anaerotruncus 、 Alistipes 、 Sutterella 、 Lactobacillus 、 Intestinibacter 、 Flavonifractor 、 Barnesiella 、 Olsenella 、 Oscillibacter 、 Streptococcus 、 Bacteroides .

[0019] In some more preferred embodiments of the present invention, the microbial marker combination includes Anaerostipes 、 Lachnoclostridium 、 Parabacteroides 、 Dialister 、 Anaerotruncus 、 Collinsella 、 Alistipes 、 Sutterella 、 Lactobacillus 、 Intestinibacter 、 Flavonifractor 、 Barnesiella 、 Olsenella 、 Oscillibacter 、 Streptococcus 、 Bacteroides .

[0020] In some more preferred embodiments of the present invention, the microbial marker combination includes Anaerostipes 、 Lachnoclostridium 、 Parabacteroides 、 Desulfovibrio 、 Dialister 、 Anaerotruncus 、 Collinsella 、 Alistipes 、 Sutterella 、 Lactobacillus 、 Intestinibacter 、 Flavonifractor 、 Barnesiella 、 Olsenella 、 Oscillibacter 、 Streptococcus 、 Bacteroides .

[0021] In some more preferred embodiments of the present invention, the microbial marker combination includes Anaerostipes 、 Lachnoclostridium 、 Parabacteroides 、 Desulfovibrio 、 Dialister 、 Anaerotruncus 、 Collinsella 、 Alistipes 、 Sutterella 、 Lactobacillus 、 Intestinibacter 、 Flavonifractor 、 Barnesiella 、 Olsenella 、 Oscillibacter 、 Streptococcus 、 Haemophilus 、 Bacteroides .

[0022] In some more preferred embodiments of the present invention, the microbial marker combination includes Anaerostipes 、 Parasutterella 、 Lachnoclostridium 、 Parabacteroides 、 Desulfovibrio 、 Dialister 、 Anaerotruncus 、 Collinsella 、 Alistipes 、 Sutterella 、 Lactobacillus 、 Intestinibacter 、 Flavonifractor 、 Barnesiella 、 Olsenella 、 Oscillibacter 、 Streptococcus 、 Haemophilus 、 Bacteroides .

[0023] In some more preferred embodiments of the present invention, the microbial marker combination includes Anaerostipes 、 Parasutterella 、 Lachnoclostridium 、 Parabacteroides 、 Desulfovibrio 、 Dialister 、 Butyricimonas 、 Anaerotruncus 、 Collinsella 、 Alistipes 、 Sutterella 、 Lactobacillus 、 Intestinibacter 、 Flavonifractor 、 Barnesiella 、 Olsenella 、 Oscillibacter 、 Streptococcus 、 Haemophilus 、 Bacteroides .

[0024] In some more preferred embodiments of the present invention, the microbial marker combination includes Anaerostipes 、 Parasutterella 、 Lachnoclostridium 、 Parabacteroids 、 Desulfovibrio 、 Dialer 、 Butyricimonas 、 Anaerotrunc 、 Collinsella 、 Akkermansia 、 Common grebe 、 Sutterella 、 Lactobacillus 、 Intestinal bacteria 、 Flavonoid 、 Barnesia 、 Olsenella 、 Oscillibacter 、 Streptococcus 、 Haemophilus 、 Bacteroides .

[0025] In some more preferred embodiments of the present invention, the microbial marker combination includes Anaerotypes 、 Parasutterella 、 Lachnoclostridium 、 Parabacteroids 、 Desulfovibrio 、 Dialer 、 Butyricimonas 、 Anaerotrunc 、 Collinsella 、 Akkermansia 、 Common grebe 、 Sutterella 、 Lactobacillus 、 Intestinal bacteria 、 Flavonoid 、 Veillonella 、 Barnesiella 、 Olsenella 、 Oscillibacter 、 Streptococcus 、 Haemophilus 、 Bacteroidea .

[0026] In some more preferred embodiments of the present invention, the microbial marker combination includes Anaerotypes 、 Parasutterella 、 Lachnoclostridium 、 Parabacteroids 、 Desulfovibrio 、 Dialer 、 Butyricimonas 、 Anaerotrunc 、 Collinsella 、 Akkermansia 、 Common grebe 、 Sutterella 、 Lactobacillus 、 Intestinal bacteria 、 Flavonoid 、 Odoric bacteria 、 Veillonella 、 Barnesia 、 Olsenella 、 Oscillibacter 、 Streptococcus 、 Haemophilus 、 Bacteroides .

[0027] In some more preferred embodiments of the present invention, the microbial marker combination includes Anaerotypes 、 Parasutterella 、 Lachnoclostridium 、 Parabacteroids 、 Desulfovibrio 、 Dialer 、 Butyricimonas 、 Anaerotrunc 、 Collinsella 、 Akkermansia 、 Common grebe 、 Sutterella 、 Lactobacillus 、 Intestinal bacteria 、 Flavonoid 、 Odoric bacteria 、 Veillonella 、 Barnesiella 、 Olsenella 、 Adlercreutzia 、 Oscillibacter 、 Streptococcus 、 Haemophilus 、 Bacteroides .

[0028] In some more preferred embodiments of the present invention, the microbial marker combination includes Anaerostipes 、 Parasutterella 、 Lachnoclostridium 、 Parabacteroides 、 Actinomyces 、 Desulfovibrio 、 Dialister 、 Butyricimonas 、 Anaerotruncus 、 Collinsella 、 Akkermansia 、 Alistipes 、 Sutterella 、 Lactobacillus 、 Intestinibacter 、 Flavonifractor 、 Odoribacter 、 Veillonella 、 Barnesiella 、 Olsenella 、 Adlercreutzia 、 Oscillibacter 、 Streptococcus 、 Haemophilus 、 Bacteroides .

[0029] In some more preferred embodiments of the present invention, the microbial marker combination includes Anaerostipes 、 Parasutterella 、 Lachnoclostridium 、 Parabacteroides 、 Actinomyces 、 Desulfovibrio 、 Dialister 、 Butyricimonas 、 Anaerotruncus 、 Alloprevotella 、 Collinsella 、 Akkermansia 、 Alistipes 、 Sutterella 、 Lactobacillus 、 Intestinibacter 、 Flavonifractor 、 Odoribacter 、 Veillonella 、 Barnesiella 、 Olsenella 、 Adlercreutzia 、 Oscillibacter 、 Streptococcus 、 Haemophilus 、 Bacteroides .

[0030] In some more preferred embodiments of the present invention, the microbial marker combination includes Anaerostipes 、 Parasutterella 、 Lachnoclostridium 、 Parabacteroides 、 Actinomyces 、 Desulfovibrio 、 Dialister 、 Butyricimonas 、 Paraprevotella 、 Anaerotruncus 、 Alloprevotella 、 Collinsella 、 Akkermansia 、 Alistipes 、 Sutterella 、 Lactobacillus 、 Intestinibacter 、 Flavonifractor 、 Odoribacter 、 Veillonella 、 Barnesiella 、 Olsenella 、 Adlercreutzia 、 Oscillibacter 、 Streptococcus 、 Haemophilus 、 Bacteroides .

[0031] In some more preferred embodiments of the present invention, the microbial marker combination includes Anaerostipes 、 Gordonibacter 、 Parasutterella 、 Lachnoclostridium 、 Parabacteroides 、 Actinomyces 、 Desulfovibrio 、 Dialister 、 Butyricimonas 、 Paraprevotella 、 Anaerotruncus 、 Alloprevotella 、 Collinsella 、 Akkermansia 、 Alistipes 、 Sutterella 、 Lactobacillus 、 Intestinibacter 、 Flavonifractor 、 Odoribacter 、 Veillonella 、 Barnesiella 、 Olsenella 、 Adlercreutzia 、 Oscillibacter 、 Streptococcus 、 Haemophilus 、 Bacteroides .

[0032] In some more preferred embodiments of the present invention, the microbial marker combination includes Anaerostipes 、 Lactococcus 、 Gordonibacter 、Parasutterella、 Lachnoclostridium 、 Parabacteroides 、 Actinomyces 、 Desulfovibrio 、 Dialister 、 Butyricimonas 、 Paraprevotella 、 Anaerotruncus 、 Alloprevotella 、 Collinsella 、 Akkermansia 、 Alistipes 、 Sutterella 、 Lactobacillus 、 Intestinibacter 、 Flavonifractor 、 Odoribacter 、 Veillonella 、 Barnesiella 、 Olsenella 、 Adlercreutzia 、 Oscillibacter 、 Streptococcus 、 Haemophilus 、 Bacteroides .

[0033] In some more preferred embodiments of the present invention, the microbial marker combination includes Anaerostipes 、 Lactococcus 、 Gordonibacter 、 Parasutterella 、 Lachnoclostridium 、 Parabacteroides 、 Actinomyces 、 Desulfovibrio 、 Dialister 、 Butyricimonas 、 Paraprevotella 、 Holdemanella 、 Anaerotruncus 、 Alloprevotella 、 Collinsella 、 Akkermansia 、 Alistipes 、 Sutterella 、 Lactobacillus 、 Intestinibacter 、 Flavonifractor 、 Odoribacter 、 Veillonella 、 Barnesiella 、 Olsenella 、 Adlercreutzia 、 Oscillibacter 、 Streptococcus 、 Haemophilus 、 Bacteroides .

[0034] In some more preferred embodiments of the present invention, the microbial marker combination includes Anaerostipes 、 Lactococcus 、 Gordonibacter 、 Parasutterella 、 Slackia 、 Lachnoclostridium 、 Parabacteroides 、 Actinomyces 、 Desulfovibrio 、 Dialister 、 Butyricimonas 、 Paraprevotella 、 Holdemanella 、 Methanobrevibacter 、 Anaerotruncus 、 Alloprevotella 、 Collinsella 、 Akkermansia 、 Alistipes 、 Sutterella 、 Lactobacillus 、 Intestinibacter 、 Flavonifractor 、 Odoribacter 、 Veillonella 、 Barnesiella 、 Olsenella 、 Adlercreutzia 、 Oscillibacter 、 Streptococcus 、 Haemophilus 、 Bacteroides .

[0035] In some more preferred embodiments of the present invention, the microbial marker combination includes Anaerostipes 、 Lactococcus 、 Gordonibacter 、 Parasutterella 、 Slackia 、 Lachnoclostridium 、 Parabacteroides 、 Actinomyces 、 Desulfovibrio 、 Dialister 、 Anaerofilum 、 Butyricimonas 、 Paraprevotella 、 Holdemanella 、 Methanobrevibacter 、 Anaerotruncus 、 Alloprevotella 、 Collinsella 、 Akkermansia 、 Alistipes 、 Sutterella 、 Lactobacillus 、 Intestinibacter 、 Flavonifractor 、 Odoribacter 、 Veillonella 、 Barnesiella 、 Olsenella 、 Adlercreutzia 、 Oscillibacter 、 Streptococcus 、 Haemophilus 、 Bacteroides .

[0036] In some more preferred embodiments of the present invention, the microbial marker combination includes Anaerostipes 、 Lactococcus 、 Gordonibacter 、 Parasutterella 、 Slackia 、 Lachnoclostridium 、 Parabacteroides 、 Actinomyces 、 Desulfovibrio 、 Dialister 、 Anaerofilum 、 Butyricimonas 、 Paraprevotella 、 Holdemanella 、 Methanobrevibacter 、 Anaerotruncus 、 Alloprevotella 、 Collinsella 、 Akkermansia 、 Alistipes 、 Sutterella 、 Lactobacillus 、 Intestinibacter 、 Flavonifractor 、 Odoribacter 、 Veillonella 、 Coprobacter 、 Barnesiella 、 Olsenella 、 Adlercreutzia 、 Oscillibacter 、 Streptococcus 、 Haemophilus 、 Bacteroides .

[0037] In some more preferred embodiments of the present invention, the microbial marker combination includes Anaerostipes 、 Lactococcus 、 Gordonibacter 、 Parasutterella 、 Slackia 、 Lachnoclostridium 、 Parabacteroides 、 Actinomyces 、 Desulfovibrio 、 Dialister 、 Anaerofilum 、 Butyricimonas 、 Paraprevotella 、 Holdemanella 、 Methanobrevibacter 、 Anaerotruncus 、 Alloprevotella 、 Collinsella 、 Akkermansia 、 Alistipes 、 Sutterella 、 Lactobacillus 、 Intestinibacter 、 Flavonifractor 、 Odoribacter 、 Veillonella 、 Coprobacter 、 Barnesiella 、 Olsenella 、 Adlercreutzia 、 Oscillibacter 、 Streptococcus 、 Marvinbryantia 、 Haemophilus 、 Bacteroides .

[0038] In some more preferred embodiments of the present invention, the microbial marker combination includes Anaerostipes 、 Lactococcus 、 Gordonibacter 、 Parasutterella 、 Slackia 、 Lachnoclostridium 、 Parabacteroides 、 Actinomyces 、 Desulfovibrio 、 Dialister 、 Anaerofilum 、 Butyricimonas 、 Paraprevotella 、 Holdemanella 、 Methanobrevibacter 、 Anaerotruncus 、 Alloprevotella 、 Collinsella 、 Akkermansia 、 Alistipes 、 Sutterella 、 Lactobacillus 、 Intestinibacter 、 Flavonifractor 、 Odoribacter 、 Veillonella 、 Coprobacter 、 Victivallis 、 Barnesiella 、 Olsenella 、 Adlercreutzia 、 Oscillibacter 、 Streptococcus 、 Marvinbryantia 、 Haemophilus 、 Bacteroides .

[0039] In some more preferred embodiments of the present invention, the microbial marker combination includes Anaerostipes 、 Lactococcus 、 Gordonibacter 、 Parasutterella 、 Slackia 、 Lachnoclostridium 、 Parabacteroides 、 Actinomyces 、 Desulfovibrio 、 Dialister 、 Anaerofilum 、 Butyricimonas 、 Paraprevotella 、 Holdemanella 、 Methanobrevibacter 、 Anaerotruncus 、 Alloprevotella 、 Collinsella 、 Turicibacter 、 Akkermansia 、 Alistipes 、 Sutterella 、 Lactobacillus 、 Intestinibacter 、 Flavonifractor 、 Odoribacter 、 Veillonella 、 Coprobacter 、 Victivallis 、 Barnesiella 、 Olsenella 、 Adlercreutzia 、 Oscillibacter 、 Streptococcus 、 Marvinbryantia 、 Haemophilus 、 Bacteroide s.

[0040] In some more preferred embodiments of the present invention, the microbial marker combination includes Anaerostipes 、 Lactococcus 、 Gordonibacter 、 Parasutterella 、 Slackia 、 Lachnoclostridium 、 Parabacteroides 、 Actinomyces 、 Desulfovibrio 、 Dialister 、 Anaerofilum 、 Butyricimonas 、 Paraprevotella 、 Holdemanella 、 Methanobrevibacter 、 Anaerotruncus 、 Alloprevotella 、 Collinsella 、 Turicibacter 、 Akkermansia 、 Alistipes 、 Hungatella 、 Sutterella 、 Lactobacillus 、 Intestinibacter 、 Flavonifractor 、 Odoribacter 、 Veillonella 、 Coprobacter 、 Victivallis 、 Barnesiella 、 Olsenella 、 Adlercreutzia 、 Oscillibacter 、 Streptococcus 、 Marvinbryantia 、 Haemophilus 、 Bacteroides .

[0041] In some more preferred embodiments of the present invention, the microbial marker combination includes Anaerostipes 、 Lactococcus 、 Gordonibacter 、 Parasutterella 、 Slackia 、 Lachnoclostridium 、 Parabacteroides 、 Actinomyces 、 Desulfovibrio 、 Dialister 、 Anaerofilum 、 Butyricimonas 、 Paraprevotella 、 Holdemanella 、 Methanobrevibacter 、 Catenibacterium 、 Anaerotruncus 、 Alloprevotella 、 Collinsella 、 Turicibacter 、 Akkermansia 、 Alistipes 、 Hungatella 、 Sutterella 、 Lactobacillus 、 Intestinibacter 、 Flavonifractor 、 Odoribacter 、 Veillonella 、 Coprobacter 、 Victivallis 、 Barnesiella 、 Olsenella 、 Adlercreutzia 、 Oscillibacter 、 Streptococcus 、 Marvinbryantia 、 Haemophilus 、 Bacteroides .

[0042] In some more preferred embodiments of the present invention, the microbial marker combination includes Anaerostipes 、 Lactococcus 、 Gordonibacter 、 Parasutterella 、 Slackia 、 Lachnoclostridium 、 Parabacteroides 、 Actinomyces 、 Desulfovibrio 、 Dialister 、 Anaerofilum 、 Butyricimonas 、 Paraprevotella 、 Holdemanella 、 Methanobrevibacter 、 Catenibacterium 、 Anaerotruncus 、 Alloprevotella 、 Collinsella 、 Turicibacter 、 Akkermansia 、 Alistipes 、 Hungatella 、 Sutterella 、 Lactobacillus 、 Intestinibacter 、 Flavonifractor 、 Odoribacter 、 Veillonella 、 Romboutsia 、 Coprobacter 、 Victivallis 、 Barnesiella 、 Olsenella 、 Adlercreutzia 、 Oscillibacter 、 Streptococcus 、 Marvinbryantia 、 Haemophilus 、 Bacteroides .

[0043] In some more preferred embodiments of the present invention, the microbial marker combination includes Anaerostipes 、 Lactococcus 、 Gordonibacter 、 Parasutterella 、 Slackia 、 Lachnoclostridium 、 Parabacteroides 、 Actinomyces 、 Desulfovibrio 、 Dialister 、 Anaerofilum 、 Butyricimonas 、 Paraprevotella 、 Holdemanella 、 Methanobrevibacter 、 Catenibacterium 、 Anaerotruncus 、 Alloprevotella 、 Collinsella 、 Turicibacter 、 Akkermansia 、 Alistipes 、 Hungatella 、 Sutterella 、 Lactobacillus 、 Butyricicoccus 、 Intestinibacter 、 Flavonifractor 、 Odoribacter 、 Veillonella 、 Romboutsia 、 Coprobacter 、 Victivallis 、 Barnesiella 、 Olsenella 、 Adlercreutzia 、 Oscillibacter 、 Streptococcus 、 Marvinbryantia 、 Haemophilus 、 Bacteroides .

[0044] In some more preferred embodiments of the present invention, the microbial marker combination includes Anaerostipes 、 Lactococcus 、 Gordonibacter 、 Parasutterella 、 Slackia 、 Lachnoclostridium 、 Parabacteroides 、 Actinomyces 、 Desulfovibrio 、 Dialister 、 Anaerofilum 、 Butyricimonas 、 Paraprevotella 、 Holdemanella 、 Methanobrevibacter 、 Catenibacterium 、 Anaerotruncus 、 Alloprevotella 、 Collinsella 、 Turicibacter 、 Akkermansia 、 Alistipes 、 Hungatella 、 Sutterella 、 Lactobacillus 、 Butyricicoccus 、 Intestinibacter 、 Flavonifractor 、 Odoribacter 、 Veillonella 、 Enterorhabdus 、 Romboutsia 、 Coprobacter 、 Victivallis 、 Barnesiella 、 Olsenella 、 Adlercreutzia 、 Oscillibacter 、 Streptococcus 、 Marvinbryantia 、 Haemophilus 、 Bacteroides .

[0045] By detecting each microorganism in the above-mentioned microbial marker combination, its abundance data is obtained, and further by constructing a machine learning model to diagnose whether the subject has type 2 diabetes or predict whether the subject has the risk of developing type 2 diabetes.

[0046] A second aspect of the present invention provides a method for constructing a type 2 diabetes diagnosis or prediction model, comprising the following steps:

[0047] S1, randomly dividing the abundance data of the microbial marker combination according to the first aspect of the present invention in biological samples of a population into two groups, one group being a training set and the other group being a test set, wherein the population includes patients with type 2 diabetes and subjects without type 2 diabetes;

[0048] S2, using the training set data, constructing the type 2 diabetes diagnosis or prediction model based on a machine learning algorithm, and performing multi-fold cross-validation;

[0049] S3. Validate the obtained type 2 diabetes diagnosis or prediction model in a test set.

[0050] It is worth noting that all steps of the method for constructing a type 2 diabetes diagnosis or prediction model of the present invention are implemented by a computer or other device.

[0051] In some embodiments of the present invention, the abundance data of each microbial marker is obtained based on qPCR, 16SrRNA sequencing or metagenomic sequencing.

[0052] In some specific embodiments of the present invention, it refers to the method obtained by 16S rRNA sequencing, specifically including:

[0053] Extracting genomic DNA from the biological sample and performing 16S rRNA sequencing to obtain sequencing data;

[0054] The raw reads of the sequencing data are preprocessed and filtered to obtain high-quality reads, which are then compared with a 16S rRNA gene reference database and chimera sequences are removed. Finally, the filtered sequences are clustered according to a certain method (including but not limited to NanoCLUST) to obtain multiple sequence clustering operational taxonomic units (OTUs), and the OTUs are annotated with taxonomy to obtain the abundance data of each microorganism.

[0055] In some embodiments of the invention, the abundance is a relative abundance.

[0056] In some embodiments of the present invention, the method further comprises the step of drawing a ROC curve to evaluate the type 2 diabetes diagnosis or prediction model.

[0057] In the present invention, the biological sample includes but is not limited to feces, intestinal lavage fluid, and anal swab samples, preferably, a feces sample.

[0058] In some embodiments of the present invention, constructing a prediction model comprises the following steps:

[0059] S1, randomly dividing the abundance data of the microbial marker combination in the biological samples of the group into two groups, one group is a training set, and the other group is a test set;

[0060] S2, using the training set data, builds a prediction model based on the machine learning algorithm and performs multi-fold cross-validation;

[0061] S3, verify the obtained prediction model in the test set.

[0062] In some embodiments of the present invention, stratified random sampling is used for grouping, and the grouping ratio can be 7:3, 4:1, etc.

[0063] In some embodiments of the present invention, the machine learning algorithm is selected from any one of the following algorithms: logistic regression algorithm, linear regression algorithm, random forest algorithm, neural network algorithm, support vector machine algorithm, Bayesian classification algorithm, gradient boosting algorithm, K nearest neighbor algorithm and decision tree algorithm.

[0064] In some specific embodiments of the present invention, the machine learning algorithm is a random forest algorithm, and the maximum depth of the prediction model obtained based on the random forest algorithm is 8, the maximum number of features is 10, the minimum number of samples required at the leaf node is 40, and the number of base evaluators is 50.

[0065] A third aspect of the present invention provides a computer device, comprising: a memory for storing a computer program; and a processor for implementing the steps of any method described in the second aspect of the present invention when executing the computer program.

[0066] A fourth aspect of the present invention provides a computer-readable storage medium having a computer program stored thereon. When the computer program is executed by a processor, the steps of any method described in the second aspect of the present invention are implemented.

[0067] A fifth aspect of the present invention provides a system for diagnosing or predicting type 2 diabetes, comprising the following modules:

[0068] A data input module, for inputting the abundance data of the microbial marker combination according to the first aspect of the present invention obtained in the subject's biological sample;

[0069] a database storage module for storing abundance data of the microbial marker combination in biological samples of a population, the population comprising type 2 diabetes patients and non-type 2 diabetes subjects;

[0070] A disease prediction module is connected to the data input module and the database storage module, respectively, and is used to construct a prediction model using the abundance data of the microbial marker combination in the biological samples of the population, and to diagnose whether the subject has type 2 diabetes or predict whether the subject has a risk of developing type 2 diabetes based on the abundance data of the microbial marker combination of the subject obtained from the data input module.

[0071] The sixth aspect of the present invention provides use of the abundance detection reagent for the microbial marker combination described in the first aspect of the present invention in the preparation of a kit for diagnosing or predicting type 2 diabetes.

[0072] In some preferred embodiments of the present invention, the abundance detection reagent refers to a high-throughput sequencing reagent, including a nucleic acid extraction, amplification reagent and / or purification reagent.

[0073] In some embodiments of the present invention, the abundance detection reagent includes primers and / or probes. Further, the probes are prepared into a chip.

[0074] Beneficial effects of the present invention

[0075] Compared with the prior art, the present invention has achieved the following beneficial effects:

[0076] Using the microbial markers of the present invention, by establishing a machine learning model, the AUC reached 0.9703 in the training set, 0.9190 in the validation set, and 0.8264 in the independent validation set, indicating that the microbial markers of the present invention can accurately diagnose whether a subject has type 2 diabetes or predict whether a subject is at risk of developing type 2 diabetes, achieve accurate prediction, enable timely medical intervention, and have great clinical application value. BRIEF DESCRIPTION OF THE DRAWINGS

[0077] Figure 1 The performance evaluation of the machine learning model in Example 2 of the present invention in the training set and the validation set is shown.

[0078] Figure 2 The performance evaluation of the machine learning model in Example 3 of the present invention in the external validation set is shown. DETAILED DESCRIPTION

[0079] Unless otherwise indicated, implied from the context, or customary in the art, all parts and percentages in this application are based on weight, and the test and characterization methods used are current as of the filing date of this application. Where applicable, the contents of any patents, patent applications, or publications referred to in this application are incorporated herein by reference in their entirety, and their equivalent patent families are also incorporated by reference, particularly for definitions of relevant terms in the art disclosed in such documents. If the definition of a specific term disclosed in the prior art is inconsistent with any definition provided in this application, the definition of the term provided in this application shall prevail.

[0080] In order to make the technical problems, technical solutions and beneficial effects solved by the present invention more clearly understood, the present invention is further described in detail below with reference to the embodiments.

[0081] The following examples are provided to illustrate preferred embodiments of the present invention. Those skilled in the art will appreciate that the techniques disclosed in the following examples represent techniques discovered by the inventors that can be used to practice the present invention and, therefore, can be considered preferred embodiments of the present invention. However, those skilled in the art will appreciate from this disclosure that many modifications may be made to the specific embodiments disclosed herein while still achieving the same or similar results without departing from the spirit or scope of the present invention.

[0082] Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs, and the disclosure and materials they cite are hereby incorporated by reference.

[0083] Those skilled in the art will recognize, or be able to ascertain using no more than routine experimentation, many technical equivalents to the specific embodiments of the invention described herein. Such equivalents are intended to be encompassed by the claims.

[0084] The experimental methods in the following examples, unless otherwise specified, are all conventional methods. The instruments and equipment used in the following examples, unless otherwise specified, are all conventional laboratory instruments and equipment; the experimental materials used in the following examples, unless otherwise specified, are all purchased from conventional biochemical reagent stores.

[0085] Example 1 Screening of intestinal microbial markers for type 2 diabetes

[0086] This example screens for intestinal microbial markers associated with type 2 diabetes. The specific screening steps are as follows:

[0087] 1. Get the dataset

[0088] Single nucleotide polymorphisms (SNPs) associated with gut microbiome (GM) were selected as instrumental variables (IVs) for exposure. The genetic variation data of these SNPs came from the MiBioGen Consortium, which analyzed 16S rRNA gene sequencing data of 18,340 participants.

[0089] The genetic variation data of type 2 diabetes are from the IEU OpenGWAS project, which contains 38 data sets, and the data numbers are: ebi-a-GCST006867, ebi-a-GCST90018926, ebi-a-GCST010118, ebi-a-GCST90013892, ebi-a-GCST90013942, ebi-a-GCST007515, ebi-a-GCST007516, bbj-a -153, bbj-a-77, ebi-a-GCST90018706, ieu-a-1090, ieu-a-23, ebi-a-GCST005413, ebi-a-GC ST005047, ieu-a-26, ieu-a-976, ebi-a-GCST90093110, ebi-a-GCST90006934, ebi-a-GCST00 8048, ebi-a-GCST90026417, ebi-a-GCST90026416, ebi-a-GCST90026415, ebi-a-GCST900264 13. ebi-a-GCST90026414, ebi-a-GCST90026412, finn-b-E4_DM2, finn-b-E4_DM2COMA, finn- b-E4_DM2KETO, finn-b-E4_DM2NEU, finn-b-E4_DM2OPTH, finn-b-E4_DM2NASCOMP, finn-b-E4_DM2PERIPH, finn-b-E4_DM2REN, finn-b-E4_DM2NOCOMP, finn-b-T2D, finn-b-T2D_INCLAVO, finn-b-E4_DM2_STRICT and finn-b-T2D_WIDE.

[0090] 2. Select instrumental variables

[0091] After excluding 15 unknown genera from the 211 intestinal microorganisms, a total of 196 intestinal microorganisms were included in this example, including 9 phylum-level microorganisms, 16 class-level microorganisms, 20 order-level microorganisms, 32 family-level microorganisms, and 119 genus-level microorganisms.

[0092] Instrumental variable inclusion criteria: The SNP significance threshold was set at P < 1.0 × 10 -5 , the linkage disequilibrium standard is r 2 <0.001, genetic distance 10000 kb, and highly correlated SNPs were removed to ensure that the included SNPs were independent of each other.

[0093] In order to eliminate the influence of weak instrumental variable bias on the estimation of association effect, the F value is used to test the strength of the instrumental variable. The calculation formula is as follows:

[0094] F=[R 2 / (R 2 -1)]×[(NK-1) / K]

[0095] Among them, N represents the sample size of the gut microbiome GWAS study, K represents the number of instrumental variables, and R 2 represents the extent to which the SNP explains the exposure, R 2 The calculation formula is: 2 =2×β 2 × (1-MAF) × MAF, MAF is the minor allele frequency, and β is the effect size of the SNP on the exposure.

[0096] F > 10 is considered to be effective in avoiding bias caused by weak instrumental variables, so SNPs with F < 10 were eliminated. A total of 1519 SNPs were obtained as instrumental variables.

[0097] 3. Statistical Analysis

[0098] Statistical analyses were performed using the TwoSampleMR and MR-PRESSO packages in R. Inverse-variance weighted (IVW) analysis was primarily used to calculate odds ratios (ORs) and 95% confidence intervals (95% CIs) to assess the potential causal association between gut microbial abundance and the risk of type 2 diabetes. MR-Egger regression, weighted median (WME), and weighted mode (WM) were used as supplementary methods to IVW.

[0099] The IVW method was used to analyze the eigenvalues, and P < 0.05 was considered statistically significant.

[0100] 4. Sensitivity and Pleiotropic Analysis

[0101] In terms of sensitivity, this example calculated Cochran's Q statistic using IVW and MR-Egger regression. A P > 0.05 indicated no significant heterogeneity. The inventors also used the leave-one-out method to remove each SNP individually to observe whether it affected the analysis results and plotted a forest plot. If a P > 0.05 was obtained after removing a SNP, the SNP was considered to have no significant effect on the results.

[0102] To examine pleiotropy, the inventors used both the intercept term of MR-Egger regression and the Mendelian randomization pleiotropy residual sum and outlier (MR-PRESSO) method to test for horizontal pleiotropy in the included SNPs. In MR-Egger regression, if the intercept approaches 0, horizontal pleiotropy is considered absent. Eigenvalues ​​with P > 0.05 were retained for horizontal pleiotropy screening.

[0103] 5. Summary Analysis

[0104] IVW is considered the standard method for summarizing MR data, which uses the Wald ratio method to calculate the causal effect estimate for each included instrument SNP and then performs a weighted summary analysis.

[0105] The results of the inverse variance weighted analysis of the above 38 data in this example are shown in Tables 1 to 38.

[0106] Table 1 IVW analysis results of ebi-a-GCST006867 data Name of intestinal microorganism Number of SNPs P OR (95% confidence interval) 3 0.036 0.8858(0.7908-0.9921) 9 0.0459 1.065(1.0012-1.133) 5 0.0023 0.8333(0.7411-0.9371) 10 0.0182 1.1155(1.0187-1.2213) 11 0.0298 0.9129(0.8408-0.9911) 11 0.0298 1.0762(1.0072-1.1498) 6 0.0366 0.9456(0.8972-0.9965) 9 0.0002 1.2185(1.0978-1.3525) 7 0.0148 1.0973(1.0183-1.1825) 12 0.019 1.1323(1.0206-1.2561)

[0107] As shown in Table 1, in ebi-a-GCST006867, Eubacterium oxidoreducens group (Redox Eubacterium group), Ruminococcus gnavus group (active rumen cocci), RuminococcaceaeUCG010 (Ruminococcaceae UCG 010), Ruminococcus torques group (Ruminococcus contortus group), RuminococcaceaeUCG003 (Ruminococcaceae UCG 003), Oscillibacter (Oscillatory Spiral), Sellimonas (Selemonas spp.), Lachnoclostridium (intestinal core bacteria), Actinomyces (Actinomyces), Streptococcus The causal relationship between Streptococcus and diabetes reached a statistically significant level (P<0.05). Ruminococcus gnavus group 、 Ruminococcus torques group 、 Oscillibacter 、 Lachnoclostridium 、 Actinomyces 、 Streptococcus It is positively correlated with the occurrence of diabetes, suggesting that it is a risk factor for diabetes; Eubacterium oxidoreducens group 、 RuminococcaceaeUCG010 、 RuminococcaceaeUCG003 and Sellimonas It is negatively correlated with the occurrence of diabetes, suggesting that it is a protective factor for diabetes.

[0108] Table 2 IVW analysis results of ebi-a-GCST90018926 data Name of intestinal microorganism Number of SNPs P OR (95% confidence interval) 11 0.0206 1.04(1.006-1.0751) 14 0.0415 0.9429(0.8912-0.9977) 14 0.0093 1.0447(1.0108-1.0796) 13 0.0109 1.1078(1.0239-1.1985) 17 0.0476 1.0701(1.0007-1.1443) 10 0.0192 0.9328(0.8801-0.9887) 9 0.0167 0.9093(0.8412-0.9829) 8 0.0003 0.8754(0.8151-0.9402) 11 0.0054 1.0535(1.0155-1.093)

[0109] As shown in Table 2, in ebi-a-GCST90018926, Lactococcus (Lactococcus lactis), RuminococcaceaeUCG003 (Ruminococcaceae UCG 003), Gordonibacter (Gordonella parvum), Ruminococcus torques group (Ruminococcus contortus group), Parasutterella (Paramastigotes), DefluviitaleaceaeUCG011 (Wastewater Bacillus family UCG011), Slackia (Slackia spp.), Oscillospira (Oscillatory Spiral), Eubacterium nodatum group The causal relationship between Eubacterium and diabetes reached a statistically significant level (P<0.05). Lactococcus 、 Gordonibacter 、 Ruminococcus torques group 、 Parasutterella 、 Eubacterium nodatum group It is positively correlated with the occurrence of diabetes, suggesting that it is a risk factor for diabetes; RuminococcaceaeUCG003 、 DefluviitaleaceaeUCG011 、 Slackia 、 Oscillospira It is negatively correlated with the occurrence of diabetes, suggesting that it is a protective factor for diabetes.

[0110] Table 3 IVW analysis results of ebi-a-GCST010118 data Name of intestinal microorganism Number of SNPs P OR (95% confidence interval) 15 0.0498 0.9448(0.8926-0.9999) 7 0.0115 0.9168(0.857-0.9806) 7 0.0481 1.0992(1.0008-1.2073) 11 0.0311 0.9286(0.868-0.9933) 11 0.0382 1.0508(1.0027-1.1011) 10 0.0217 1.0464(1.0066-1.0877) 11 0.024 0.9121(0.8421-0.9879) 9 0.0282 1.0483(1.0051-1.0934) 13 0.0286 1.0744(1.0076-1.1457)

[0111] As shown in Table 3, in ebi-a-GCST010118, Erysipelatoclostridium (Erysipelothrix spp.), Enterorhabdus (Enterobacter spp.), RuminococcaceaeUCG010 (Ruminococcaceae UCG 010), Romboutsia (Rombus spp.), Coprobacter (Coprococcus spp.), Victivallis (Food Pseudomonas), Ruminococcus1 (Ruminococcus spp.), Eubacterium nodatum group (Eubacterium spp.), Lachnospiraceae NK4A136 groupThe causal relationship between Lachnospiraceae and diabetes reached a statistically significant level (P<0.05). RuminococcaceaeUCG010 、 Coprobacter 、 Victivallis 、 Eubacterium nodatum group 、 Lachnospiraceae NK4A136 group It is positively correlated with the occurrence of diabetes, suggesting that it is a risk factor for diabetes; Erysipelatoclostridium 、 Enterorhabdus 、 Romboutsia 、 Ruminococcus1 It is negatively correlated with the occurrence of diabetes, suggesting that it is a protective factor for diabetes.

[0112] Table 4 IVW analysis results of ebi-a-GCST90013892 data Name of intestinal microorganism Number of SNPs P OR (95% confidence interval) 13 0.0425 1.1412(1.0045-1.2966) 8 0.0006 0.8552(0.7821-0.9352) 6 0.0204 0.8318(0.7118-0.9719) 7 0.0488 1.1152(1.0006-1.243) 12 0.023 0.8641(0.7618-0.98) 12 0.048 0.8617(0.7435-0.9987) 6 0.0063 0.8224(0.7149-0.9462) 10 0.0498 0.8859(0.7849-0.9999) 11 0.0058 0.8639(0.7786-0.9585)

[0113] As shown in Table 4, in ebi-a-GCST90013892, Lachnoclostridium (intestinal core bacteria), LachnospiraceaeNC2004 group (Lachnospiraceae), Parabacteroides (Parabacteroides spp.), Actinomyces (Actinomyces), RuminococcaceaeUCG003 (Ruminococcaceae UCG003), Coprococcus1 (Coprococcus spp. 1), RuminococcaceaeUCG010 (Ruminococcaceae UCG010), Desulfovibrio (Desulfovibrio spp.), Dialister The causal relationship between Dialisterella and diabetes reached a statistically significant level (P<0.05). Lachnoclostridium 、 Actinomyces It is positively correlated with the occurrence of diabetes, suggesting that it is a risk factor for diabetes; LachnospiraceaeNC2004 group 、 Parabacteroides 、 RuminococcaceaeUCG003 、 Coprococcus1 、 RuminococcaceaeUCG01 0. Desulfovibrio 、 Dialister It is negatively correlated with the occurrence of diabetes, suggesting that it is a protective factor for diabetes.

[0114] Table 5 IVW analysis results of ebi-a-GCST90013942 data Name of intestinal microorganism Number of SNPs P OR (95% confidence interval) 10 0.0486 0.8856(0.7849-0.9993) 11 0.0061 0.8643(0.7788-0.9592) 6 0.0213 0.8326(0.7124-0.9731) 7 0.0489 1.1152(1.0005-1.243) 12 0.0252 0.8654(0.7624-0.9822) 13 0.0425 1.1412(1.0045-1.2966) 12 0.047 0.8613(0.7432-0.998) 8 0.0006 0.8553(0.7821-0.9354) 6 0.0063 0.8224(0.7149-0.9462)

[0115] As shown in Table 5, in ebi-a-GCST90013942, Desulfovibrio (Desulfovibrio spp.), Dialister (Diarlisteria spp.), Parabacteroides (Parabacteroides spp.), Actinomyces (Actinomyces), RuminococcaceaeUCG003 (Ruminococcaceae UCG003), Lachnoclostridium (intestinal core bacteria), Coprococcus1 (Coprococcus spp. 1), L achnospiraceaeNC2004 group (Lachnospiraceae), RuminococcaceaeUCG010 The causal relationship between (Ruminococcaceae UCG010) and diabetes reached a statistically significant level (P<0.05). Lachnoclostridium 、 Actinomyces It is positively correlated with the occurrence of diabetes, suggesting that it is a risk factor for diabetes; Desulfovibrio 、 Dialister 、 Parabacteroides 、 RuminococcaceaeUCG003 、 Coprococcus1 、 LachnospiraceaeNC2004 group 、 RuminococcaceaeUCG010 It is negatively correlated with the occurrence of diabetes, suggesting that it is a protective factor for diabetes.

[0116] Table 6 IVW analysis results of ebi-a-GCST007515 data Name of intestinal microorganism Number of SNPs P OR (95% confidence interval) 3 0.0423 1.0985(1.0033-1.2029)

[0117] As shown in Table 6, in ebi-a-GCST007515, Victivallis The causal relationship between (Food Pseudomonas) and diabetes reached a statistically significant level (P<0.05). In addition, Victivallis It is positively correlated with the occurrence of diabetes, suggesting that it is a risk factor for diabetes.

[0118] Table 7 IVW analysis results of ebi-a-GCST007516 data Name of intestinal microorganism Number of SNPs P OR (95% confidence interval) 3 0.02 1.12(1.018-1.2322)

[0119] As shown in Table 7, in ebi-a-GCST007516, Victivallis The causal relationship between (Food Pseudomonas) and diabetes reached a statistically significant level (P<0.05). In addition, Victivallis It is positively correlated with the occurrence of diabetes, suggesting that it is a risk factor for diabetes.

[0120] Table 8 IVW analysis results of bbj-a-153 data Name of intestinal microorganism Number of SNPs P OR (95% confidence interval) 9 0.0489 1.0502(1.0002-1.1026) 10 0.0317 1.1186(1.0099-1.2391) 11 0.0426 0.8959(0.8056-0.9963)

[0121] From Table 8, we can see that in bbj-a-153, Olsenella (Lactobacillus spp.), Anaerostipes (Lachnospiraceae Anaerostipes genus), Ruminiclostridium9 The causal relationship between (Ruminal Clostridium 9) and diabetes reached a statistically significant level (P<0.05). Olsenella 、 Anaerostipes It is positively correlated with the occurrence of diabetes, suggesting that it is a risk factor for diabetes; Ruminiclostridium9 It is negatively correlated with the occurrence of diabetes, suggesting that it is a protective factor for diabetes.

[0122] Table 9 IVW analysis results of bbj-a-77 data Name of intestinal microorganism Number of SNPs P OR (95% confidence interval) 10 0.0145 1.1097(1.0209-1.2063) 11 0.0316 1.0887(1.0075-1.1765) 9 0.0212 1.0628(1.0092-1.1192)

[0123] From Table 9, we can see that in bbj-a-77, Adlercreutzia (Adlerkreutzia spp.), Holdemanella (Holdemania spp.), Olsenella The causal relationship between Lactobacillus spp. and diabetes reached a statistically significant level (P<0.05). Adlercreutzia 、 Holdemanella 、 Olsenella It is positively correlated with the occurrence of diabetes, suggesting that it is a risk factor for diabetes.

[0124] Table 10 IVW analysis results of ebi-a-GCST90018706 data Name of intestinal microorganism Number of SNPs P OR (95% confidence interval) 10 0.0342 0.9297(0.869-0.9946) 10 0.0306 1.0639(1.0058-1.1254) 10 0.024 1.0544(1.007-1.1041)

[0125] As shown in Table 10, in ebi-a-GCST90018706, Anaerofilum (Lachnospiraceae Anaerofilum genus), Eubacterium nodatum group (Eubacterium spp.), Lactococcus The causal relationship between Lactococcus lactis and diabetes reached a statistically significant level (P<0.05). Eubacterium nodatum group 、 Lactococcus It is positively correlated with the occurrence of diabetes, suggesting that it is a risk factor for diabetes; Anaerofilum It is negatively correlated with the occurrence of diabetes, suggesting that it is a protective factor for diabetes.

[0126] Table 11 IVW analysis results of IEU-A-1090 data Name of intestinal microorganism Number of SNPs P OR (95% confidence interval) 12 0.0234 0.5626(0.3422-0.925) 11 0.0061 0.732(0.5856-0.915) 19 0.01 1.4241(1.088-1.8639) 11 0.0345 0.7314(0.5473-0.9775) 17 0.0192 1.5727(1.0766-2.2974) 15 0.0368 1.3584(1.019-1.8108)

[0127] From Table 11, we can see that in IEU-A-1090, Ruminiclostridium5 (Ruminal Clostridium 5), Lactococcus (Lactococcus lactis), Eubacterium ruminantium group (Eubacterium ruminantum), Howardella (Howardia spp.), Butyricimonas (Butyricum spp.), Erysipelatoclostridium The causal relationship between Erysipelothrix (Erysipelothrix) and diabetes reached a statistically significant level (P<0.05). Eubacterium ruminantium group 、 Butyricimonas 、 Erysipelatoclostridium It is positively correlated with the occurrence of diabetes, suggesting that it is a risk factor for diabetes; Ruminiclostridium5、 Lactococcus 、 Howardella It is negatively correlated with the occurrence of diabetes, suggesting that it is a protective factor for diabetes.

[0128] Table 12 IVW analysis results of IEU-A-23 data Name of intestinal microorganism Number of SNPs P OR (95% confidence interval) 4 0.0418 1.2801(1.0092-1.6236) 8 0.0095 0.78(0.6464-0.9412) 3 0.0262 1.295(1.031-1.6266) 9 0.0293 1.1381(1.0131-1.2785) 11 0.0176 0.845(0.7354-0.9711) 4 0.005 1.5051(1.1314-2.0021) 9 0.0031 1.311(1.0958-1.5684) 7 0.0112 0.7904(0.6591-0.948) 7 0.0183 0.8151(0.6878-0.966)

[0129] From Table 12, we can see that in IEU-A-23, Ruminiclostridium9 (Clostridium rumenii 9), Ruminococcaceae NK4A214 group (Ruminococcaceae NK4A214), Holdemanella (Holdemania spp.), Ruminococcus gnavus group (active rumen cocci), Parasutterella (Paramastigotes), Parabacteroides (Parabacteroides spp.), Lachnoclostridium (intestinal core bacteria), Marvinbryantia (Marvinberry), Akkermansia The causal relationship between Akkermansia and diabetes reached a statistically significant level (P<0.05). Ruminiclostridium9 、 Holdemanella 、 Ruminococcus gnavus group 、 Parabacteroides 、 Lachnoclostridium It is positively correlated with the occurrence of diabetes, suggesting that it is a risk factor for diabetes; Ruminococcaceae NK4A214 group 、 Parasutterella 、 Marvinbryantia 、 Akkermansia It is negatively correlated with the occurrence of diabetes, suggesting that it is a protective factor for diabetes.

[0130] Table 13 IVW analysis results of ebi-a-GCST005413 data Name of intestinal microorganism Number of SNPs P OR (95% confidence interval) 19 0.037 1.1091(1.0062-1.2225) 11 0.0308 1.124(1.0109-1.2498) 15 0.0214 1.1972(1.027-1.3956) 15 0.0166 0.825(0.7049-0.9656)

[0131] As shown in Table 13, in ebi-a-GCST005413, Eubacterium ruminantium group (Eubacterium ruminantum), Howardella (Howardia spp.), Eubacterium ventriosum group (Eubacterium venosus), Family XIIIAD3011 group The causal relationship with diabetes reached a statistically significant level (P<0.05). Eubacterium ruminantium group 、 Howardella 、 Eubacterium ventriosum group It is positively correlated with the occurrence of diabetes, suggesting that it is a risk factor for diabetes; Family XIIIAD3011 group It is negatively correlated with the occurrence of diabetes, suggesting that it is a protective factor for diabetes.

[0132] Table 14 IVW analysis results of ebi-a-GCST005047 data Name of intestinal microorganism Number of SNPs P OR (95% confidence interval) 9 0.0059 1.2889(1.0758-1.5443) 9 0.0154 1.1641(1.0294-1.3164) 3 0.0468 1.2477(1.0031-1.5518) 8 0.0207 0.7909(0.6484-0.9647) 4 0.0052 1.5285(1.1347-2.0588) 7 0.0196 0.8015(0.6656-0.9652) 4 0.0297 1.2862(1.0251-1.6138) 7 0.0279 0.8287(0.701-0.9798) 5 0.0499 0.8608(0.741-0.9999) 6 0.0467 0.7765(0.6051-0.9963) 11 0.017 0.8344(0.7191-0.9682)

[0133] As shown in Table 14, in ebi-a-GCST005047, Lachnoclostridium (intestinal core bacteria), Ruminococcus gnavus group (active rumen cocci), Holdemanella (Holdemania), Ruminococcaceae NK4A214 group (Ruminococcaceae NK4A214), Parabacteroides (Parabacteroides spp.), Marvinbryantia (Marvinberry), Ruminiclostridium9 (Clostridium rumenii 9), Akkermansia (Akkermansia), Haemophilus (Haemophilus spp.), Bacteroides (Bacteroides spp.), Parasutterella The causal relationship between (Paraflagellate spp.) and diabetes reached a statistically significant level (P<0.05). Lachnoclostridium 、 Ruminococcus gnavus group 、 Holdemanella 、 Parabacteroides 、 Ruminiclostridium9 It is positively correlated with the occurrence of diabetes, suggesting that it is a risk factor for diabetes; Ruminococcaceae NK4A214 group 、 Marvinbryantia 、 Akkermansia 、 Haemophilus 、 Bacteroides 、 Parasutterella It is negatively correlated with the occurrence of diabetes, suggesting that it is a protective factor for diabetes.

[0134] Table 15 IVW analysis results of IEU-A-26 data Name of intestinal microorganism Number of SNPs P OR (95% confidence interval) 11 0.038 1.3162(1.0153-1.7062) 8 0.0258 0.7488(0.5806-0.9657) 3 0.0321 0.7311(0.549-0.9737) 8 0.0071 1.4231(1.1006-1.84)

[0135] From Table 15, we can see that in IEU-A-26, Streptococcus (Streptococcus spp.), Ruminococcaceae NK4A214 group (Ruminococcaceae NK4A214), Actinomyces (Actinomyces), Lachnoclostridium The causal relationship between (intestinal core bacteria) and diabetes reached a statistically significant level (P<0.05). Streptococcus 、 Lachnoclostridium It is positively correlated with the occurrence of diabetes, suggesting that it is a risk factor for diabetes; Ruminococcaceae NK4A214 group 、 Actinomyces It is negatively correlated with the occurrence of diabetes, suggesting that it is a protective factor for diabetes.

[0136] Table 16 IVW analysis results of IEU-A-976 data Name of intestinal microorganism Number of SNPs P OR (95% confidence interval) 7 0.0265 0.8337(0.71-0.979) 7 0.0367 0.7252(0.5364-0.9803)

[0137] From Table 16, we can see that in IEU-A-976, Howardella (Howardia spp.), Akkermansia The causal relationship between Akkermansia and diabetes reached a statistically significant level (P<0.05). Howardella 、 Akkermansia It is negatively correlated with the occurrence of diabetes, suggesting that it is a protective factor for diabetes.

[0138] Table 17 IVW analysis results of ebi-a-GCST90093110 data Name of intestinal microorganism Number of SNPs P OR (95% confidence interval) 13 0.0064 1.2926(1.0747-1.5547)

[0139] As shown in Table 17, in ebi-a-GCST90093110, Anaerostipes (Lachnospiraceae Anaerostipes The causal relationship between genus (genus) and diabetes reached a statistically significant level (P<0.05). It was positively correlated with the occurrence of diabetes, suggesting that it is a risk factor for diabetes.

[0140] Table 18 IVW analysis results of ebi-a-GCST90006934 data Name of intestinal microorganism Number of SNPs P OR (95% confidence interval) 24 0.0495 0.8586(0.7375-0.9997) 14 0.0228 0.8637(0.7613-0.9798) 12 0.0272 1.1227(1.0131-1.2442) 6 0.0069 1.2747(1.0687-1.5203) 9 0.019 0.8613(0.7602-0.9758) 16 0.0025 0.7611(0.6377-0.9083) 8 0.008 0.7484(0.6041-0.9272)

[0141] As shown in Table 18, in ebi-a-GCST90006934, RuminococcaceaeUCG002 (Ruminococcaceae UCG002), Coprobacter (Coprococcus spp.), RikenellaceaeRC9 gut group (RIKEN RC9 intestinal group), Eubacterium oxidoreducens group (Redox Eubacterium group), Eubacterium fissicatena group (Eubacterium scissorium), Barnesiella (Barnesella spp.), Flavonifractor The causal relationship between (Flavonobacterium) and diabetes reached a statistically significant level (P<0.05). RikenellaceaeRC9 gut group 、 Eubacterium oxidoreducens group It is positively correlated with the occurrence of diabetes, suggesting that it is a risk factor for diabetes; RuminococcaceaeUCG002 、 Coprobacter 、 Eubacterium fissicatena group 、 Barnesiella 、 Flavonifractor It is negatively correlated with the occurrence of diabetes, suggesting that it is a protective factor for diabetes.

[0142] Table 19 IVW analysis results of ebi-a-GCST008048 data Name of intestinal microorganism Number of SNPs P OR (95% confidence interval) 12 0.0208 1.1485(1.0213-1.2917) 24 0.0094 0.847(0.7472-0.9601) 13 0.0238 1.224(1.0272-1.4584)

[0143] As shown in Table 19, in ebi-a-GCST008048, Eisenbergiella(Eisenbergia spp.), RuminococcaceaeUCG002 (Ruminococcaceae UCG002), Lachnoclostridium The causal relationship between (intestinal core bacteria) and diabetes reached a statistically significant level (P<0.05). Eisenbergiella 、 Lachnoclostridium It is positively correlated with the occurrence of diabetes, suggesting that it is a risk factor for diabetes; RuminococcaceaeUCG002 It is negatively correlated with the occurrence of diabetes, suggesting that it is a protective factor for diabetes.

[0144] Table 20 IVW analysis results of ebi-a-GCST90026417 data Name of intestinal microorganism Number of SNPs P OR (95% confidence interval) 17 0.0406 0.7234(0.5306-0.9863)

[0145] As shown in Table 20, in ebi-a-GCST90026417, Fusicatenibacter The causal relationship between the genus Spindle and diabetes reached a statistically significant level (P<0.05). It was negatively correlated with the occurrence of diabetes, suggesting that it is a protective factor for diabetes.

[0146] Table 21 IVW analysis results of ebi-a-GCST90026416 data Name of intestinal microorganism Number of SNPs P OR (95% confidence interval) 18 0.0356 0.6731(0.4653-0.9736) 15 0.0289 1.6297(1.0516-2.5258) 15 0.021 0.668(0.4742-0.9409)

[0147] As shown in Table 21, in ebi-a-GCST90026416, Fusicatenibacter (Spindle chain), FamilyXIIIAD3011 group 、 Escherichia.Shigella The causal relationship between Escherichia coli and diabetes reached a statistically significant level (P<0.05). FamilyXIIIAD3011group It is positively correlated with the occurrence of diabetes, suggesting that it is a risk factor for diabetes; Fusicatenibacter 、 Escherichia.Shigella It is negatively correlated with the occurrence of diabetes, suggesting that it is a protective factor for diabetes.

[0148] Table 22 IVW analysis results of ebi-a-GCST90026415 data Name of intestinal microorganism Number of SNPs P OR (95% confidence interval) 16 0.0184 0.6337(0.4338-0.9259) 18 0.0387 0.5791(0.3451-0.972) 12 0.0388 0.7004(0.4997-0.9818) 14 0.0261 0.6939(0.5029-0.9575) 8 0.0298 0.7009(0.5086-0.9658)

[0149] As shown in Table 22, in ebi-a-GCST90026415, Butyricimonas (Butyricum spp.), Fusicatenibacter (Spindle chain), Paraprevotella (Escherichia), Holdemanella (Holdemania spp.), Methanobrevibacter The causal relationship between Methanobacterium and diabetes reached a statistically significant level (P<0.05). It was negatively correlated with the development of diabetes, suggesting that it is a protective factor for diabetes.

[0150] Table 23 IVW analysis results of ebi-a-GCST90026413 data Name of intestinal microorganism Number of SNPs P OR (95% confidence interval) 5 0.0485 0.6745(0.4561-0.9975)

[0151] As shown in Table 23, in ebi-a-GCST90026413, Catenibacterium The causal relationship between Streptobacillus (Small Streptobacillus) and diabetes reached a statistically significant level (P<0.05). It was negatively correlated with the occurrence of diabetes, suggesting that it is a protective factor for diabetes.

[0152] Table 24 IVW analysis results of ebi-a-GCST90026414 data Name of intestinal microorganism Number of SNPs P OR (95% confidence interval) 14 0.0421 1.7001(1.0192-2.8358) 9 0.0196 0.5122(0.292-0.8985) 13 0.0048 2.3272(1.2933-4.1876)

[0153] As shown in Table 24, in ebi-a-GCST90026414, Coprococcus1 (Coprococcus spp. 1), Coprococcus2 (Coprococcus spp. 2), Anaerotruncus ( Anaerotruncus The causal relationship between the two groups (P<0.05) reached a statistically significant level. Coprococcus1 、 Anaerotruncus It is positively correlated with the occurrence of diabetes, suggesting that it is a risk factor for diabetes; Coprococcus2 It is negatively correlated with the occurrence of diabetes, suggesting that it is a protective factor for diabetes.

[0154] Table 25 IVW analysis results of ebi-a-GCST90026412 data Name of intestinal microorganism Number of SNPs P OR (95% confidence interval) 7 0.0462 1.6134(1.0081-2.5819) 11 0.0438 0.4961(0.251-0.9806) 11 0.0472 0.4354(0.1915-0.9897) 12 0.0287 2.0588(1.0778-3.9326) 12 0.0376 2.0116(1.041-3.8874)

[0155] As shown in Table 25, in ebi-a-GCST90026412, Alloprevotella (Pseudoprevotella spp.), RuminococcaceaeUCG004 (Ruminococcaceae UCG004), Collinsella (Collinsella spp.), Turicibacter (Zurichobacterium spp.), Akkermansia The causal relationship between Akkermansia and diabetes reached a statistically significant level (P<0.05). Alloprevotella 、 Turicibacter 、 Akkermansia It is positively correlated with the occurrence of diabetes, suggesting that it is a risk factor for diabetes; RuminococcaceaeUCG004 、 Collinsella It is negatively correlated with the occurrence of diabetes, suggesting that it is a protective factor for diabetes.

[0156] Table 26 IVW analysis results of finn-b-E4_DM2 data Name of intestinal microorganism Number of SNPs P OR (95% confidence interval) 16 0.025 1.0926(1.0112-1.1806) 12 0.0326 0.9133(0.8403-0.9925) 8 0.0027 0.8369(0.7449-0.9403) 14 0.0363 0.9044(0.8232-0.9936)

[0157] As shown in Table 26, in finn-b-E4_DM2, Parasutterella (Paramastigotes), Turicibacter (Zurichobacterium spp.), RuminococcaceaeUCG010 (Ruminococcaceae UCG010), Ruminiclostridium5 The causal relationship between (Ruminal Clostridium 5) and diabetes reached a statistically significant level (P<0.05). Parasutterella It is positively correlated with the occurrence of diabetes, suggesting that it is a risk factor for diabetes; Turicibacter 、 RuminococcaceaeUCG010 、 Ruminiclostridium5 It is negatively correlated with the occurrence of diabetes, suggesting that it is a protective factor for diabetes.

[0158] Table 27 finn-b-E4_DM2COMA data IVW analysis results Name of intestinal microorganism Number of SNPs P OR (95% confidence interval) 17 0.0221 0.7338(0.563-0.9565) 13 0.0194 1.4152(1.0578-1.8935) 14 0.0156 0.703(0.5284-0.9354) 4 0.0002 1.6915(1.2847-2.2272) 19 0.0324 0.8237(0.6896-0.9839) 13 0.0351 1.4562(1.0265-2.0657) 6 0.0241 1.3811(1.0431-1.8284)

[0159] As shown in Table 27, in finn-b-E4_DM2COMA, ErysipelotrichaceaeUCG003 (Erysipelothrixaceae UCG 003), Ruminococcus gauvreauii group (Ruminococcus glaucifolius), RuminococcaceaeUCG00 3 (Ruminococcaceae UCG003), Catenibacterium (Streptobacillus), Eubacterium ruminantium group (Eubacterium ruminantum), LachnospiraceaeUCG004 (Lachnospira UCG004), Eubacterium oxidoreducens group The causal relationship between Eubacterium oxidoreductum and diabetes reached a statistically significant level (P<0.05). Ruminococcus gauvreauii group 、 Catenibacterium 、 LachnospiraceaeUCG004 、 Eubacterium oxidoreducens group It is positively correlated with the occurrence of diabetes, suggesting that it is a risk factor for diabetes; ErysipelotrichaceaeUCG003 、 RuminococcaceaeUCG003 、 Eubacterium ruminantium group It is negatively correlated with the occurrence of diabetes, suggesting that it is a protective factor for diabetes.

[0160] Table 28 IVW analysis results of finn-b-E4_DM2KETO data Name of intestinal microorganism Number of SNPs P OR (95% confidence interval) 8 0.0211 2.2132(1.1265-4.3484) 17 0.0033 0.3242(0.1528-0.6875) 12 0.0165 1.5999(1.0898-2.3487) 12 0.0431 1.9535(1.0211-3.7373) 13 0.0066 3.9525(1.4664-10.6535) 5 0.0236 2.4919(1.1305-5.4928) 14 0.0154 1.8136(1.1206-2.935) 8 0.0342 0.6056(0.3807-0.9634)

[0161] As shown in Table 28, in finn-b-E4_DM2KETO, Actinomyces (Actinomyces), RuminococcaceaeUCG014 (Ruminococcaceae UCG014), RikenellaceaeRC9 gut group (RIKEN RC9 intestinal group), Eisenbergiella(Eisenbergia spp.), Alistipes (Another mycobacterium), Hungatella (Clostridium family Hungatella genus), Holdemanella (Holdemania spp.), RuminococcaceaeUCG011 The causal relationship between (Ruminococcaceae UCG011) and diabetes reached a statistically significant level (P<0.05). Actinomyces 、 RikenellaceaeRC9 gut group 、 Eisenbergiella 、 Alistipes 、 Hungatella 、 Holdemanella It is positively correlated with the occurrence of diabetes, suggesting that it is a risk factor for diabetes; RuminococcaceaeUCG014 、 RuminococcaceaeUCG011 It is negatively correlated with the occurrence of diabetes, suggesting that it is a protective factor for diabetes.

[0162] Table 29 IVW analysis results of finn-b-E4_DM2NEU data Name of intestinal microorganism Number of SNPs P OR (95% confidence interval) 12 0.0331 0.5976(0.3722-0.9595)

[0163] As shown in Table 29, in finn-b-E4_DM2NEU, Sutterella The causal relationship between Sutterella and diabetes reached a statistically significant level (P<0.05). It was negatively correlated with the occurrence of diabetes, suggesting that it is a protective factor for diabetes.

[0164] Table 30 IVW analysis results of finn-b-E4_DM2OPTH data Name of intestinal microorganism Number of SNPs P OR (95% confidence interval) 9 0.0191 1.3278(1.0476-1.6829) 8 0.0259 1.3887(1.0403-1.8538) 14 0.0135 0.8129(0.6898-0.9581)

[0165] As shown in Table 30, in finn-b-E4_DM2OPTH, Lactobacillus (Lactobacillus spp.), Actinomyces (Actinomyces), Gordonibacter The causal relationship between (Gordonella paramecium) and diabetes reached a statistically significant level (P<0.05). Lactobacillus 、 Actinomyces It is positively correlated with the occurrence of diabetes, suggesting that it is a risk factor for diabetes; Gordonibacter It is negatively correlated with the occurrence of diabetes, suggesting that it is a protective factor for diabetes.

[0166] Table 31 IVW analysis results of finn-b-E4_DM2NASCOMP data Name of intestinal microorganism Number of SNPs P OR (95% confidence interval) 9 0.0055 0.8247(0.7197-0.9449) 10 0.0302 0.8886(0.7986-0.9887) 8 0.0007 0.7977(0.6996-0.9094)

[0167] As shown in Table 31, in finn-b-E4_DM2NASCOMP, Butyricicoccus (Butyric acid bacteria), Desulfovibrio(Desulfovibrio spp.), RuminococcaceaeUCG010 The causal relationship between Ruminococcaceae UCG010 and diabetes reached a statistically significant level (P<0.05). It was negatively correlated with the development of diabetes, suggesting that it is a protective factor for diabetes.

[0168] Table 32 IVW analysis results of finn-b-E4_DM2PERIPH data Name of intestinal microorganism Number of SNPs P OR (95% confidence interval) 9 0.0244 0.5784(0.359-0.9318) 9 0.0018 1.6913(1.2166-2.3512) 15 0.0272 0.6567(0.4521-0.9538) 12 0.034 0.7374(0.5564-0.9773) 13 0.0031 2.0699(1.2773-3.3541) 12 0.0225 0.5871(0.3716-0.9275) 10 0.0195 0.5716(0.3575-0.9139)

[0169] As shown in Table 32, in finn-b-E4_DM2PERIPH, Coprococcus2 (Coprococcus spp. 2), Lactobacillus (Lactobacillus spp.), Intestinibacter ( Intestinibacter genus), Anaerofilum (Lachnospiraceae Anaerofilum genus), Lachnoclostridium (intestinal core bacteria), LachnospiraceaeUCG010 (Lachnospira UCG010), FamilyXIIIUCG001 The causal relationship with diabetes reached a statistically significant level (P<0.05). Lactobacillus 、 Lachnoclostridium It is positively correlated with the occurrence of diabetes, suggesting that it is a risk factor for diabetes; Coprococcus2 、 Intestinibacter 、 Anaerofilum 、 LachnospiraceaeUCG010 、 FamilyXIIIUCG001 It is negatively correlated with the occurrence of diabetes, suggesting that it is a protective factor for diabetes.

[0170] Table 33 IVW analysis results of finn-b-E4_DM2REN data Name of intestinal microorganism Number of SNPs P OR (95% confidence interval) 12 0.0041 1.7174(1.1866-2.4856) 8 0.031 1.5905(1.0434-2.4244) 12 0.0223 0.6291(0.4228-0.936)

[0171] As shown in Table 33, in finn-b-E4_DM2REN, Akkermansia (Akkermansia), Flavonifractor (Flavonoids), Sutterella The causal relationship between Sutterella and diabetes reached a statistically significant level (P<0.05). Akkermansia 、 Flavonifractor It is positively correlated with the occurrence of diabetes, suggesting that it is a risk factor for diabetes; Sutterella It is negatively correlated with the occurrence of diabetes, suggesting that it is a protective factor for diabetes.

[0172] Table 34. IVW analysis results of finn-b-E4_DM2NOCOMP data Name of intestinal microorganism Number of SNPs P OR (95% confidence interval) 15 0.0444 1.1785(1.0041-1.3831) 15 0.0169 1.1729(1.029-1.3369) 8 0.0356 1.2089(1.0129-1.4429) 9 0.0276 0.8272(0.6987-0.9793) 8 0.0033 0.7901(0.675-0.9247) 8 0.016 1.2939(1.0492-1.5956)

[0173] As shown in Table 34, in finn-b-E4_DM2NOCOMP, Anaerostipes (Lachnospiraceae Anaerostipes genus), Escherichia.Shigella (Escherichia), Odoribacter ( Odoribacter genus), Butyricicoccus (Butyric acid bacteria), RuminococcaceaeUCG010 (Ruminococcaceae UCG010), Parabacteroides The causal relationship between (Parabacteroides spp.) and diabetes reached a statistically significant level (P<0.05). Anaerostipes 、 Escherichia.Shigella 、 Odoribacter 、 Parabacteroides It is positively correlated with the occurrence of diabetes, suggesting that it is a risk factor for diabetes; Butyricicoccus 、 RuminococcaceaeUCG010 It is negatively correlated with the occurrence of diabetes, suggesting that it is a protective factor for diabetes.

[0174] Table 35 IVW analysis results of finn-b-T2D data Name of intestinal microorganism Number of SNPs P OR (95% confidence interval) 12 0.0277 0.9072(0.8318-0.9894) 11 0.0491 1.0629(1.0003-1.1295) 8 0.019 0.865(0.7663-0.9764) 9 0.0287 0.8692(0.7667-0.9855) 8 0.0341 1.1278(1.0091-1.2606) 16 0.028 1.1055(1.0109-1.209)

[0175] As shown in Table 35, in finn-b-T2D, Turicibacter (Zurichobacterium spp.), Clostridium innocuum group (harmless Clostridium group), RuminococcaceaeUCG010 (Ruminococcaceae UCG010), Butyricicoccus (Butyric acid bacteria), Actinomyces (Actinomyces), Parasutterella The causal relationship between (Paraflagellate spp.) and diabetes reached a statistically significant level (P<0.05). Clostridium innocuum group 、 Actinomyces 、 Parasutterella It is positively correlated with the occurrence of diabetes, suggesting that it is a risk factor for diabetes; Turicibacter 、 RuminococcaceaeUCG010 、 Butyricicoccus It is negatively correlated with the occurrence of diabetes, suggesting that it is a protective factor for diabetes.

[0176] Table 36 IVW analysis results of finn-b-T2D_INCLAVO data Name of intestinal microorganism Number of SNPs P OR (95% confidence interval) 16 0.0129 1.12(1.0243-1.2246) 8 0.033 1.1405(1.0107-1.287)

[0177] As shown in Table 36, in finn-b-T2D_INCLAVO, Actinomyces (Actinomyces), Parasutterella ( The causal relationship between Paramastigotes and diabetes reached a statistically significant level (P<0.05). It was positively correlated with the development of diabetes, suggesting that it is a risk factor for diabetes.

[0178] Table 37 IVW analysis results of finn-b-E4_DM2_STRICT data Name of intestinal microorganism Number of SNPs P OR (95% confidence interval) 8 0.0379 1.1282(1.0067-1.2643) 12 0.0319 0.9094(0.8338-0.9918) 8 0.0146 0.8599(0.7618-0.9707) 16 0.0266 1.1072(1.0119-1.2115) 11 0.0453 1.064(1.0013-1.1307) 9 0.0315 0.8713(0.7685-0.9879)

[0179] As shown in Table 37, in finn-b-E4_DM2_STRICT, Actinomyces (Actinomyces), Turicibacter (Zurichobacterium spp.), RuminococcaceaeUCG010 (Ruminococcaceae UCG010), Parasutterella (Paramastigotes), Clostridium innocuum group (harmless Clostridium group), Butyricicoccus The causal relationship between Butyric acid bacteria and diabetes reached a statistically significant level (P<0.05). Actinomyces 、 Parasutterella 、 Clostridium innocuum group It is positively correlated with the occurrence of diabetes, suggesting that it is a risk factor for diabetes; Turicibacter 、 RuminococcaceaeUCG010 、 Butyricicoccus It is negatively correlated with the occurrence of diabetes, suggesting that it is a protective factor for diabetes.

[0180] Table 38 IVW analysis results of finn-b-T2D_WIDE data Name of intestinal microorganism Number of SNPs P OR (95% confidence interval) 4 0.0328 1.1487(1.0114-1.3046) 3 0.0426 1.3493(1.0101-1.8026) 9 0.0057 1.1967(1.0536-1.3591) 8 0.0158 1.2248(1.0388-1.4441) 8 0.0019 0.7691(0.6517-0.9078) 15 0.0369 1.1256(1.0072-1.258)

[0181] As shown in Table 38, in finn-b-T2D_WIDE, Catenibacterium (Streptobacillus), LachnospiraceaeND3007group (Lachnospira ND3007 group), Veillonella (Veillonella spp.), Odoribacter ( Odoribacter genus), RuminococcaceaeUCG010 (Ruminococcaceae UCG010), Escherichia.Shigella The causal relationship between Escherichia coli and diabetes reached a statistically significant level (P<0.05). Catenibacterium 、 LachnospiraceaeND3007group 、 Veillonella 、 Odoribacter 、 Escherichia.Shigella It is positively correlated with the occurrence of diabetes, suggesting that it is a risk factor for diabetes; RuminococcaceaeUCG010 It is negatively correlated with the occurrence of diabetes, suggesting that it is a protective factor for diabetes.

[0182] Example 2 Machine Learning Model for Predicting Type 2 Diabetes

[0183] This example uses the RandomForestClassifier function in the Python sklearn.ensemble module to perform random forest algorithm modeling on the data.

[0184] This example constructs a prediction model for calculating the host's risk of type 2 diabetes based on the abundance values ​​of intestinal microbial markers screened in Example 1. The specific steps are as follows:

[0185] S1. Dataset acquisition: 888 sample data were downloaded from the MicroPhenoDB database, including 500 cases in the control group and 388 cases in the case group.

[0186] S2, the StandardScaler function of the klearn.preprocessing module standardizes the data, and then uses the recursive feature elimination method for feature selection. The recursive feature elimination method uses a base model for multiple rounds of training. After each round of training, several unimportant features are eliminated, and then the next round of training is based on the new feature set. It uses model accuracy to identify which attribute combinations contribute the most to predicting the target attribute, and then eliminates useless features. Sklearn provides two recursive feature elimination methods, namely recursive feature elimination (RFE) and cross-recursive feature elimination (RFECV). The present invention uses RFE recursive feature elimination method for feature value screening, and determines the optimal feature set based on the AUC value of the model test set. The optimal feature set has 31 features, namely: Anaerostipes 、 Lactococcus 、 Gordonibacter 、 Parasutterella 、 Lachnoclostridium 、 Parabacteroides 、 Actinomyces 、 Desulfovibrio 、 Dialister 、 Butyricimonas 、 Paraprevotella 、 Holdemanella 、 Methanobrevibacter 、 Anaerotruncus 、 Alloprevotella 、 Collinsella 、 Akkermansia 、 Alistipes 、 Sutterella 、 Lactobacillus 、 Intestinibacter 、 Flavonifractor 、 Odoribacter 、 Veillonella 、 Barnesiella 、 Olsenella 、 Adlercreutzia 、 Oscillibacter 、 Streptococcus 、 Haemophilus and Bacteroides The 31 intestinal microbial characteristics will be used for subsequent model construction and prediction.

[0187] S3, the train_test_split function divides the dataset into a training set and an internal validation set. In this embodiment, 25% of the samples are used as the internal validation set.

[0188] S4. A random forest model is established using cross-validation and continuously optimized. In this embodiment, the most suitable parameter combination is selected using a parameter grid search method. The model prediction effect is best when max_depth = 8, max_features = 10, n_estimators = 50, and min_samples_leaf = 40.

[0189] The ROC curves of the training set and the validation set are as follows Figure 1 As shown, the accuracy of the training set is 91.59%, AUC=0.9703, and the accuracy of the validation set is 83.78%, AUC=0.919.

[0190] Example 3: Evaluation of model performance in independent validation sets

[0191] The inventors applied the type 2 diabetes prediction model constructed using Example 2 to an independent validation set.

[0192] The independent validation set primarily consisted of real-world physical examination sample data. The sample type was fecal, totaling 40 samples, including 15 from patients with type 2 diabetes and 25 from healthy controls. Nanopore 16S rRNA sequencing was used for analysis. The specific analysis steps are as follows:

[0193] (1) Sequencing

[0194] DNA extraction: DNA was extracted using a fecal sample bacterial genome extraction kit, and the extracted DNA concentration and purity were tested using Nanodrop;

[0195] 16S rRNA amplification: Targeted amplification of the V4 region of the bacterial 16S rRNA gene was performed using a 16S sequencing library construction kit for 30 cycles. The reaction conditions were: 95°C for 1 min, 94°C for 30 s, 62°C for 30 s, 62°C for 2 min, and 62°C for 5 min; then maintained at 4°C.

[0196] Recover PCR products: Purify the target fragment using AMPure XP beads and quantify using Qubit;

[0197] Adapter ligation: Combine the barcoded libraries according to their concentrations to create a 10 μL system, ensuring a total DNA volume of 200 ng. Add 1 μL of Rapid Sequencing Adapter (RAP) to the mixed sample, gently pipette to mix, and incubate at room temperature for 5 minutes.

[0198] Finally, the constructed library was sequenced using the GridION nanopore sequencer.

[0199] (2) Bioinformatics Analysis

[0200] First, NanoStat software was used to quality control, filter, and remove sequencing adapters from the raw data to obtain high-quality reads. Minimap2 global alignment was used to identify chimeras, which were then removed using yacrd. Filtlong software was then used to filter the data for specific lengths and Q values. Finally, the filtered sequences were clustered using a specific method (NanoCLUST in this example) to obtain multiple sequence clustering operational taxonomic units (OTUs). These OTUs were then annotated with taxonomy to obtain species abundance information.

[0201] (3) Model prediction

[0202] The abundance information of intestinal microbial markers in the case group and the control group was sorted out, and then model prediction and risk level classification were performed.

[0203] The prediction analysis of the above independent validation set was performed using the model constructed in Example 2. The results are as follows: Figure 2 As shown, AUC = 0.8264, with an accuracy of 76%. The above results show that the model constructed using Example 2 can distinguish patients with type 2 diabetes from healthy subjects and can be used clinically to assist in the diagnosis of whether a subject has type 2 diabetes.

[0204] All documents mentioned in this application are incorporated herein by reference, just as if each document were incorporated herein by reference individually. It should also be understood that after reading the above teachings of the present invention, those skilled in the art may make various changes or modifications to the present invention, and that such equivalents also fall within the scope of the claims appended hereto.

Claims

1. A combination of microbial markers for diagnosing or predicting type 2 diabetes, characterized in that: The microbial marker combination includes Anaerostipes , Lactococcus , Gordonibacter , Parasutterella , Lachnoclostridium , Parabacteroides , Actinomyces , Desulfovibrio , Dialister , Butyricimonas , Paraprevotella , Holdemanella , Methanobrevibacter , Anaerotruncus , Alloprevotella , Collinsella , Akkermansia , Alistipes , Sutterella , Lactobacillus , Intestinibacter , Flavonifractor , Odoribacter , Veillonella , Barnesiella , Olsenella , Adlercreutzia , Oscillibacter , Streptococcus , Haemophilus and Bacteroides .

2. A method for constructing a type 2 diabetes diagnosis or prediction model, characterized in that: The following steps are involved: S1, randomly dividing the abundance data of the combination of microbial markers described in claim 1 in biological samples of a population into two groups, one group being a training set and the other group being a test set, wherein the population includes patients with type 2 diabetes and subjects without type 2 diabetes; S2, using the training set data, constructing the type 2 diabetes diagnosis or prediction model based on the machine learning algorithm, and performing multi-fold cross validation; S3, verifying the obtained type 2 diabetes diagnosis or prediction model in a test set.

3. The method according to claim 2, characterized in that The abundance data of the microbial marker combination is obtained based on qPCR, 16S rRNA sequencing or metagenomic sequencing.

4. The method according to claim 2, characterized in that: The method further comprises the step of drawing a ROC curve to evaluate the type 2 diabetes diagnosis or prediction model.

5. The method according to claim 1, characterized in that The machine learning algorithm is selected from any one of the following algorithms: Logistic regression algorithm, linear regression algorithm, random forest algorithm, neural network algorithm, support vector machine algorithm, Bayesian classification algorithm, gradient boosting algorithm, K nearest neighbor algorithm and decision tree algorithm.

6. The method according to claim 5, characterized in that The machine learning algorithm is a random forest algorithm. The maximum depth of the prediction model obtained based on the random forest algorithm is 8, the maximum number of features is 10, the minimum number of samples required at the leaf node is 40, and the number of base evaluators is 50.

7. A computer device, characterized in that: include: Memory for storing computer programs; A processor, configured to implement the steps of the method according to any one of claims 2 to 6 when executing the computer program.

8. A computer-readable storage medium, characterized in that: The computer-readable storage medium stores a computer program, and when the computer program is executed by a processor, the steps of the method according to any one of claims 2 to 6 are implemented.

9. A system for diagnosing or predicting type 2 diabetes, characterized in that: Includes the following modules: A data input module, used to input the abundance data of the microbial marker combination according to claim 1 obtained in the subject's biological sample; A database storage module, for storing the abundance data of the microbial marker combination in biological samples of a population, the population including type 2 diabetes patients and non-type 2 diabetes subjects; A disease prediction module is connected to the data input module and the database storage module, respectively, and is used to construct a prediction model using the abundance data of the microbial marker combination in the biological samples of the population, and to diagnose whether the subject has type 2 diabetes or predict whether the subject has a risk of developing type 2 diabetes based on the abundance data of the microbial marker combination of the subject obtained from the data input module.

10. Use of the abundance detection reagent of the microbial marker combination according to claim 1 in the preparation of a kit for diagnosing or predicting type 2 diabetes.

Citation Information

Patent Citations

  • Microbial marker of type II diabetes mellitus and application of microbial marker

    CN110129431A

  • Application of reagent for detecting intestinal microorganisms and / or excrement metabolites in preparation of diabetes diagnosis preparation and kit

    CN116223803A

  • Method for predicting gestational diabetes mellitus based on ensemble learning of intestinal flora markers

    CN116469559A

  • Application of microbial marker in diagnosis of hyperglycemia-related diseases

    CN117887870A

  • Method and system for constructing gestational diabetes mellitus judgment model based on machine learning

    CN118039116A

Cited By

  • Type 2 diabetes mellitus prediction method and system based on microorganism co-abundance characteristics

    CN121790004A

  • A method and system for predicting type 2 diabetes based on microbial co-abundance features

    CN121790004B